Development and validation of a PCR‐based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs — Dimitra Stefanou (2012) | RDL Network
Development and validation of a PCR‐based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs
Article 2012 en
Authors
DS
Dimitra Stefanou
HE
Hara Episkopou
SK
Soterios Α. Kyrtopoulos
Abstract
1 min read
The PCR-based assay developed in this study can be used for the selection of cancer patients more likely to benefit from therapeutic treatment with alkylating drugs.
Hoyt Burdick, Carson Lam, Samson Mataraso, Anna Siefkas, Gregory L. Braden, R. Phillip Dellinger, Andrea J. McCoy, Jean Louis Vincent, Abigail Green‐Saxena, Gina Barnes, Jana Hoffman, Jacob Calvert, Emily Pellegrini, Ritankar Das
Athina Markou, Tina Bagratuni, Christina Tsakiri, Victoria Tserpeli, Stamatia Skourti, Nefeli Mavrianou Koutsoukou, Alexandra Papadimou, Evangelos Terpos, Efstathios Kastritis, Evi Lianidou, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.